Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Centre Hospitalier Universitaire, Amiens
Aspergillosis disease is a growing problem. These diseases are not yet uncommon in chronic obstructive pulmonary disease patients. (COPD).
Aspergillosis disease are very difficult to be diagnosed or treated. Isolation of aspergillus in sputum of patients is not always responsible of a real disease. Need of treatment is discussed. That is why, we will conduct a prospective cohort study to evaluate aspergillus rate in respiratory samples of COPD patients (GOLD stage III or IV)
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
COPD patients GOLD stage III and IV
You may not be if
Cystic fibrosis
Pulmonary fibrosis
hematological malignancy
known aspergilloma
allergic bronchopulmonary aspergillosis
Clareo Health | Aspergillus and Chronic Obstructive Pulmonary Disease Evolution